|Journal of the Pancreas is believed to publish the most validated review articles on Islet cell carcinoma. With the support of eminent editorial board and efficient reviewers entire peer-reviewing process is done through editorial manager system which assures the publication of high quality articles related to Islet cell carcinoma.
Islet cell carcinoma is an uncommon cancer of the endocrine pancreas. It accounts for approximately 1.3% of pancreatic cancer. It is also known as or nesidioblastoma. Pancreatic islet cell tumors can be benign or malignant. Islet cells produce many different hormones; most tumors release only one hormone that leads to specific symptoms. There are different types of islet cell tumor such as: Gastrinomas (Zollinger-Ellison syndrome), Glucagonomas, Insulinomas. Islet cell tumors are treatable even after they have metastasized. Symptoms include sweating, Headache, Hunger, anxiety, Double or blurry vision, pounding heartbeat, Diarrhea, Ulcers in the stomach and small bowel, Vomiting blood etc.
OMICS Group, the leading online open access publisher systematically maintains more than 700+ peer-reviewed journals, Journal of the Pancreas being one among them are supported by very efficient editorial board and have more than 3 millionâs reader database. The other wing of OMICS International, OMICS Group conferences, successfully organizes around 3000+ International Scientific Conferences annually on emerging research topics in the fields of medical, clinical, engineering and life sciences.